References: |
BX517 is a novel phosphoinositide-dependent kinase-1 (PDK1) inhibitor. For the detailed information of BIX517, the solubility of BIX517 in water, the solubility of BIX517 in DMSO, the solubility of BIX517 in PBS buffer, the animal experiment (test) of BIX517, the cell expriment (test) of BIX517, the in vivo, in vitro and clinical trial test of BIX517, the EC50, IC50,and affinity,of BIX517, For the detailed information of BIX517, the solubility of BIX517 in water, the solubility of BIX517 in DMSO, the solubility of BIX517 in PBS buffer, the animal experiment (test) of BIX517, the cell expriment (test) of BIX517, the in vivo, in vitro and clinical trial test of BIX517, the EC50, IC50,and affinity,of BIX517, Please contact DC Chemicals. |